Hiroya Kobayashi

Asahikawa Medical University — Japan

Immunology and Microbiology · Life Sciences

32h-index3.0kcitations157works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(69), Immune Cell Function and Interaction(38), Cancer Immunotherapy and Biomarkers(31), vaccines and immunoinformatics approaches(27), CAR-T cell therapy research(24)

Publications157 total

Figure 1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025Open Access
Figure 2 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025Open Access
Figure S3 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025Open Access
Figure S2 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025Open Access
Table S1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025Open Access
Figure S1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025Open Access
Figure S4 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025Open Access
Figure 4 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025Open Access
Data from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025Open Access
Figure 3 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025Open Access
Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
Cancer Research Communications·2025Open Access
Synergistic activation of STING and CD40 in the tumor microenvironment enhances CD8+ T-cell-dependent antitumor immunity
Biochemical and Biophysical Research Communications·2025· 1 citedOpen Access
ROR1 as an Immunotherapeutic Target for Inducing Antitumor Helper T Cell Responses Against Head and Neck Squamous Cell Carcinoma
Cancers·2025Open Access
Tumor-promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti-tumor helper T cells in head and neck squamous cell carcinoma
Cancer Immunology Immunotherapy·2025Open Access
Differences in <scp>PD</scp>‐<scp>L1</scp>, <scp>PD</scp>‐<scp>L2</scp>, and <scp>EGFR</scp> Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study
Head & Neck·2025· 2 citedOpen Access
Interleukin-6/soluble IL-6 receptor-induced secretion of cathepsin B and L from human gingival fibroblasts is regulated by caveolin-1 and ERK1/2 pathways
Frontiers in Dental Medicine·2025Open Access
Bond and Cracking Characteristics of PVA-Fiber-Reinforced Cementitious Composite Reinforced with Braided AFRP Bars
Fibers·2023· 5 citedOpen Access
Data from Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition
2023Open Access
Supplementary Figure Legends from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
Data from Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Esteban Celis(28), Toshihiro Nagato(23), Kensuke Oikawa(23), Naoko Aoki(23), Yasuaki Harabuchi(23), Shoji Kimura(22), Takumi Kumai(19), Keisuke Sato(16), Takayuki Ohkuri(15), Masatoshi Tateno(14), Akemi Kosaka(12), Kenzo Ohara(11), Kei Ishibashi(8), Miki Takahara(6), Marino Nagata(6), Shohei Harabuchi(6), Ryusuke Hayashi(6), Kan Kishibe(5), Ryusuke Omiya(5), Yuki Yajima(5)